1 mRNA Vaccine Market Overview |
1.1 Product Overview and Scope of mRNA Vaccine |
1.2 mRNA Vaccine Segment by Type |
| 1.2.1 Global mRNA Vaccine Sales Growth Rate Comparison by Type (2021-2026) |
| 1.2.2 Standardization Of Cancer Treatment mRNA Vaccine |
| 1.2.3 Individualized Cancer Treatment mRNA Vaccine |
| 1.2.4 Infectious Disease Treatment mRNA Vaccine |
| 1.2.5 Infection Prevention mRNA Vaccine |
1.3 mRNA Vaccine Segment by Application |
| 1.3.1 mRNA Vaccine Sales Comparison by Application: 2020 VS 2026 |
| 1.3.2 Infectious Disease |
| 1.3.3 Cancer |
| 1.3.4 Other |
1.4 Global mRNA Vaccine Market Size Estimates and Forecasts |
| 1.4.1 Global mRNA Vaccine Revenue 2015-2026 |
| 1.4.2 Global mRNA Vaccine Sales 2015-2026 |
| 1.4.3 mRNA Vaccine Market Size by Region: 2020 Versus 2026 |
2 Global mRNA Vaccine Market Competition by Manufacturers |
2.1 Global mRNA Vaccine Sales Market Share by Manufacturers (2015-2020) |
2.2 Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020) |
2.3 Global mRNA Vaccine Average Price by Manufacturers (2015-2020) |
2.4 Manufacturers mRNA Vaccine Manufacturing Sites, Area Served, Product Type |
2.5 mRNA Vaccine Market Competitive Situation and Trends |
| 2.5.1 mRNA Vaccine Market Concentration Rate |
| 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue |
| 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) |
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans |
2.7 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders) |
3 mRNA Vaccine Retrospective Market Scenario by Region |
3.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 |
3.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 |
3.3 North America mRNA Vaccine Market Facts & Figures by Country |
| 3.3.1 North America mRNA Vaccine Sales by Country |
| 3.3.2 North America mRNA Vaccine Sales by Country |
| 3.3.3 U.S. |
| 3.3.4 Canada |
3.4 Europe mRNA Vaccine Market Facts & Figures by Country |
| 3.4.1 Europe mRNA Vaccine Sales by Country |
| 3.4.2 Europe mRNA Vaccine Sales by Country |
| 3.4.3 Germany |
| 3.4.4 France |
| 3.4.5 U.K. |
| 全:文：http://www.qdlaimaiche.com/8/78/Global-mRNA-Vaccine-Industry-Analysis-and-Trends-Analysis-Report-2020-2026.html |
| 3.4.6 Italy |
| 3.4.7 Russia |
3.5 Asia PacifiA Vaccine Market Facts & Figures by Region |
| 3.5.1 Asia PacifiA Vaccine Sales by Region |
| 3.5.2 Asia PacifiA Vaccine Sales by Region |
| 3.5.3 China |
| 3.5.4 Japan |
| 3.5.5 South Korea |
| 3.5.6 India |
| 3.5.7 Australia |
| 3.5.8 Taiwan, China |
| 3.5.9 Indonesia |
| 3.5.10 Thailand |
| 3.5.11 Malaysia |
| 3.5.12 Philippines |
| 3.5.13 Vietnam |
3.6 Latin America mRNA Vaccine Market Facts & Figures by Country |
| 3.6.1 Latin America mRNA Vaccine Sales by Country |
| 3.6.2 Latin America mRNA Vaccine Sales by Country |
| 3.6.3 Mexico |
| 3.6.3 Brazil |
| 3.6.3 Argentina |
3.7 Middle East and Africa mRNA Vaccine Market Facts & Figures by Country |
| 3.7.1 Middle East and Africa mRNA Vaccine Sales by Country |
| 3.7.2 Middle East and Africa mRNA Vaccine Sales by Country |
| 3.7.3 Turkey |
| 3.7.4 Saudi Arabia |
| 3.7.5 U.A.E |
4 Global mRNA Vaccine Historic Market Analysis by Type |
4.1 Global mRNA Vaccine Sales Market Share by Type (2015-2020) |
4.2 Global mRNA Vaccine Revenue Market Share by Type (2015-2020) |
4.3 Global mRNA Vaccine Price Market Share by Type (2015-2020) |
4.4 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End |
5 Global mRNA Vaccine Historic Market Analysis by Application |
5.1 Global mRNA Vaccine Sales Market Share by Application (2015-2020) |
5.2 Global mRNA Vaccine Revenue Market Share by Application (2015-2020) |
5.3 Global mRNA Vaccine Price by Application (2015-2020) |
6 Company Profiles and Key Figures in mRNA Vaccine Business |
6.1 Company 1 |
| 6.1.1 Corporation Information |
| 6.1.2 Company 1 Description, Business Overview and Total Revenue |
| 6.1.3 Moderna TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.1.4 Company 1 Products Offered |
| 6.1.5 Company 1 Recent Development |
6.2 Company 2 |
| 6.2.1 CureVaA Vaccine Production Sites and Area Served |
| 6.2.2 Company 2 Description, Business Overview and Total Revenue |
| 6.2.3 CureVaA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.2.4 Company 2 Products Offered |
| 6.2.5 Company 2 Recent Development |
6.3 Company 3 |
| 6.3.1 Company 3 mRNA Vaccine Production Sites and Area Served |
| 6.3.2 Company 3 Description, Business Overview and Total Revenue |
| 6.3.3 Company 3 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.3.4 Company 3 Products Offered |
| 6.3.5 Company 3 Recent Development |
6.4 Company 4 |
| 6.4.1 Company 4 mRNA Vaccine Production Sites and Area Served |
| 6.4.2 Company 4 Description, Business Overview and Total Revenue |
| 6.4.3 Company 4 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.4.4 Company 4 Products Offered |
| 6.4.5 Company 4 Recent Development |
6.5 Company 5 |
| 6.5.1 Sangamo TherapeutiRNA Vaccine Production Sites and Area Served |
| 6.5.2 Company 5 Description, Business Overview and Total Revenue |
| 6.5.3 Sangamo TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.5.4 Company 5 Products Offered |
| 6.5.5 Company 5 Recent Development |
6.6 Company 6 |
| 6.6.1 Argos TherapeutiRNA Vaccine Production Sites and Area Served |
| 6.6.2 Company 6 Description, Business Overview and Total Revenue |
| 6.6.3 Argos TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.6.4 Company 6 Products Offered |
| 6.6.5 Company 6 Recent Development |
6.7 Company 7 |
| 6.6.1 Company 7 mRNA Vaccine Production Sites and Area Served |
| 6.6.2 Company 7 Description, Business Overview and Total Revenue |
| 6.6.3 Company 7 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.4.4 Company 7 Products Offered |
| 6.7.5 Company 7 Recent Development |
6.8 Company 8 |
| 6.8.1 Company 8 mRNA Vaccine Production Sites and Area Served |
| 6.8.2 Company 8 Description, Business Overview and Total Revenue |
| 6.8.3 Company 8 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 全球疫苗基因行業分析及發展趨勢分析報告2020至2026年 |
| 6.8.4 Company 8 Products Offered |
| 6.8.5 Company 8 Recent Development |
6.9 Company 9 |
| 6.9.1 Company 9 mRNA Vaccine Production Sites and Area Served |
| 6.9.2 Company 9 Description, Business Overview and Total Revenue |
| 6.9.3 Company 9 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.9.4 Company 9 Products Offered |
| 6.9.5 Company 9 Recent Development |
6.10 Company 10 |
| 6.10.1 Company 10 mRNA Vaccine Production Sites and Area Served |
| 6.10.2 Company 10 Description, Business Overview and Total Revenue |
| 6.10.3 Company 10 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020) |
| 6.10.4 Company 10 Products Offered |
| 6.10.5 Company 10 Recent Development |
7 mRNA Vaccine Manufacturing Cost Analysis |
7.1 mRNA Vaccine Key Raw Materials Analysis |
| 7.1.1 Key Raw Materials |
| 7.1.2 Key Raw Materials Price Trend |
| 7.1.3 Key Suppliers of Raw Materials |
7.2 Proportion of Manufacturing Cost Structure |
7.3 Manufacturing Process Analysis of mRNA Vaccine |
7.4 mRNA Vaccine Industrial Chain Analysis |
8 Marketing Channel, Distributors and Customers |
8.1 Marketing Channel |
8.2 mRNA Vaccine Distributors List |
8.3 mRNA Vaccine Customers |
9 Market Dynamics |
9.1 Market Trends |
9.2 Opportunities and Drivers |
9.3 Challenges |
9.4 Porter's Five Forces Analysis |
10 Global Market Forecast |
10.1 Global mRNA Vaccine Market Estimates and Projections by Type |
| 10.1.1 Global Forecasted Sales of mRNA Vaccine by Type (2021-2026) |
| 10.1.2 Global Forecasted Revenue of mRNA Vaccine by Type (2021-2026) |
10.2 mRNA Vaccine Market Estimates and Projections by Application |
| 10.2.1 Global Forecasted Sales of mRNA Vaccine by Application (2021-2026) |
| 10.2.2 Global Forecasted Revenue of mRNA Vaccine by Application (2021-2026) |
10.3 mRNA Vaccine Market Estimates and Projections by Region |
| 10.3.1 Global Forecasted Sales of mRNA Vaccine by Region (2021-2026) |
| 10.3.2 Global Forecasted Revenue of mRNA Vaccine by Region (2021-2026) |
10.4 North America mRNA Vaccine Estimates and Projections (2021-2026) |
10.5 Europe mRNA Vaccine Estimates and Projections (2021-2026) |
10.6 Asia PacifiA Vaccine Estimates and Projections (2021-2026) |
10.7 Latin America mRNA Vaccine Estimates and Projections (2021-2026) |
10.8 Middle East and Africa mRNA Vaccine Estimates and Projections (2021-2026) |
11 Research Finding and Conclusion |
12 Methodology and Data Source |
12.1 Methodology/Research Approach |
| 12.1.1 Research Programs/Design |
| 12.1.2 Market Size Estimation |
| 12.1.3 Market Breakdown and Data Triangulation |
12.2 Data Source |
| 12.2.1 Secondary Sources |
| 12.2.2 Primary Sources |
12.3 Author List |
12.4 Disclaimer |
| List of Tables |
| Table 1. Global mRNA Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026) |
| Table 2. Global mRNA Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026 |
| Table 3. Global mRNA Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026) |
| Table 4. Global Key mRNA Vaccine Manufacturers Covered in This Study |
| Table 5. Global mRNA Vaccine Sales (K Doses) by Manufacturers (2015-2020) |
| Table 6. Global mRNA Vaccine Sales Share by Manufacturers (2015-2020) |
| Table 7. Global mRNA Vaccine Revenue (Million USD) by Manufacturers (2015-2020) |
| Table 8. Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020) |
| Table 9. Global Market mRNA Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020) |
| Table 10. Manufacturers mRNA Vaccine Sales Sites and Area Served |
| Table 11. Manufacturers mRNA Vaccine Product Types |
| Table 12. Global mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) |
| Table 13. Global mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019) |
| Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans |
| Table 15. Main Points Interviewed from Key mRNA Vaccine Players |
| Table 16. Global mRNA Vaccine Sales (K Doses) by Region (2015-2020) |
| Table 17. Global mRNA Vaccine Sales Market Share by Region (2015-2020) |
| Table 18. Global mRNA Vaccine Revenue (Million US$) by Region (2015-2020) |
| Table 19. Global mRNA Vaccine Revenue Market Share by Region (2015-2020) |
| Table 20. North America mRNA Vaccine Sales by Country (2015-2020) (K Doses) |
| Table 21. North America mRNA Vaccine Sales Market Share by Country (2015-2020) |
| Table 22. North America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million) |
| Table 23. North America mRNA Vaccine Revenue Market Share by Country (2015-2020) |
| Table 24. Europe mRNA Vaccine Sales by Country (2015-2020) (K Doses) |
| Table 25. Europe mRNA Vaccine Sales Market Share by Country (2015-2020) |
| Table 26. Europe mRNA Vaccine Revenue by Country (2015-2020) (US$ Million) |
| 全球疫苗基因行業分析及發展趨勢分析報告2020至2026年 |
| Table 27. Europe mRNA Vaccine Revenue Market Share by Country (2015-2020) |
| Table 28. Asia PacifiA Vaccine Sales by Region (2015-2020) (K Doses) |
| Table 29. Asia PacifiA Vaccine Sales Market Share by Region (2015-2020) |
| Table 30. Asia PacifiA Vaccine Revenue by Region (2015-2020) (US$ Million) |
| Table 31. Asia PacifiA Vaccine Revenue Market Share by Region (2015-2020) |
| Table 32. Latin America mRNA Vaccine Sales by Country (2015-2020) (K Doses) |
| Table 33. Latin America mRNA Vaccine Sales Market Share by Country (2015-2020) |
| Table 34. Latin America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million) |
| Table 35. Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020) |
| Table 36. Middle East and Africa mRNA Vaccine Sales by Country (2015-2020) (K Doses) |
| Table 37. Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020) |
| Table 38. Middle East and Africa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million) |
| Table 39. Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020) |
| Table 40. Global mRNA Vaccine Sales (K Doses) by Type (2015-2020) |
| Table 41. Global mRNA Vaccine Sales Share by Type (2015-2020) |
| Table 42. Global mRNA Vaccine Revenue (Million US$) by Type (2015-2020) |
| Table 43. Global mRNA Vaccine Revenue Share by Type (2015-2020) |
| Table 44. Global mRNA Vaccine Price (USD/Dose) by Type (2015-2020) |
| Table 45. Global mRNA Vaccine Sales (K Doses) by Application (2015-2020) |
| Table 46. Global mRNA Vaccine Sales Market Share by Application (2015-2020) |
| Table 47. Global mRNA Vaccine Sales Growth Rate by Application (2015-2020) |
| Table 48. Moderna TherapeutiRNA Vaccine Corporation Information |
| Table 49. Company 1 Description and Business Overview |
| Table 50. Moderna TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 51. Moderna Therapeutiain Product |
| Table 52. Company 1 Recent Development |
| Table 53. CureVaA Vaccine Corporation Information |
| Table 54. Company 2 Corporation Information |
| Table 55. CureVaA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 56. Company 2 Main Product |
| Table 57. Company 2 Recent Development |
| Table 58. Company 3 mRNA Vaccine Corporation Information |
| Table 59. Company 3 Corporation Information |
| Table 60. Company 3 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 61. Company 3 Main Product |
| Table 62. Company 3 Recent Development |
| Table 63. Company 4 mRNA Vaccine Corporation Information |
| Table 64. Company 4 Corporation Information |
| Table 65. Company 4 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 66. Company 4 Main Product |
| Table 67. Company 4 Recent Development |
| Table 68. Sangamo TherapeutiRNA Vaccine Corporation Information |
| Table 69. Company 5 Corporation Information |
| Table 70. Sangamo TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 71. Sangamo Therapeutiain Product |
| Table 72. Company 5 Recent Development |
| Table 73. Argos TherapeutiRNA Vaccine Corporation Information |
| Table 74. Company 6 Corporation Information |
| Table 75. Argos TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 76. Argos Therapeutiain Product |
| Table 77. Company 6 Recent Development |
| Table 78. Company 7 mRNA Vaccine Corporation Information |
| Table 79. Company 7 Corporation Information |
| Table 80. Company 7 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 81. Company 7 Main Product |
| Table 82. Company 7 Recent Development |
| Table 83. Company 8 mRNA Vaccine Corporation Information |
| Table 84. Company 8 Corporation Information |
| Table 85. Company 8 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 86. Company 8 Main Product |
| Table 87. Company 8 Recent Development |
| Table 88. Company 9 mRNA Vaccine Corporation Information |
| Table 89. Company 9 Corporation Information |
| Table 90. Company 9 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 91. Company 9 Main Product |
| Table 92. Company 9 Recent Development |
| Table 93. Company 10 mRNA Vaccine Corporation Information |
| Table 94. Company 10 Corporation Information |
| Table 95. Company 10 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 96. Company 10 Main Product |
| Table 97. Company 10 Recent Development |
| Table 98. Sales Base and Market Concentration Rate of Raw Material |
| Table 99. Key Suppliers of Raw Materials |
| Table 100. mRNA Vaccine Distributors List |
| Table 101. mRNA Vaccine Customers List |
| Table 102. Market Key Trends |
| Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) |
| Table 104. Key Challenges |
| Table 105. Global mRNA Vaccine Sales (K Doses) Forecast by Type (2021-2026) |
| Table 106. Global mRNA Vaccine Sales Market Share Forecast by Type (2021-2026) |
| Table 107. Global mRNA Vaccine Revenue (Million US$) Forecast by Type (2021-2026) |
| Table 108. Global mRNA Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) |
| Table 109. Global mRNA Vaccine Sales (K Doses) Forecast by Application (2021-2026) |
| Table 110. Global mRNA Vaccine Revenue (Million US$) Forecast by Application (2021-2026) |
| quánqiú yìmiáo jīyīn hángyè fēnxī jí fāzhǎn qūshì fēnxī bàogào 2020 zhì 2026 nián |
| Table 111. Global mRNA Vaccine Sales (K Doses) Forecast by Region (2021-2026) |
| Table 112. Global mRNA Vaccine Sales Market Share Forecast by Region (2021-2026) |
| Table 113. Global mRNA Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) |
| Table 114. Global mRNA Vaccine Revenue Market Share Forecast by Region (2021-2026) |
| Table 115. Research Programs/Design for This Report |
| Table 116. Key Data Information from Secondary Sources |
| Table 117. Key Data Information from Primary Sources |
| List of Figures |
| Figure 1. Picture of mRNA Vaccine |
| Figure 2. Global mRNA Vaccine Sales Market Share by Type: 2020 VS 2026 |
| Figure 3. Standardization Of Cancer Treatment mRNA Vaccine Product Picture |
| Figure 4. Individualized Cancer Treatment mRNA Vaccine Product Picture |
| Figure 5. Infectious Disease Treatment mRNA Vaccine Product Picture |
| Figure 6. Infection Prevention mRNA Vaccine Product Picture |
| Figure 7. Global mRNA Vaccine Consumption Market Share by Application: 2020 VS 2026 |
| Figure 8. Infectious Disease |
| Figure 9. Cancer |
| Figure 10. Other |
| Figure 11. Global mRNA Vaccine Market Size 2015-2026 (US$ Million) |
| Figure 12. Global mRNA Vaccine Sales Capacity (K Doses) (2015-2026) |
| Figure 13. Global mRNA Vaccine Market Size Market Share by Region: 2020 Versus 2026 |
| Figure 14. mRNA Vaccine Sales Share by Manufacturers in 2020 |
| Figure 15. Global mRNA Vaccine Revenue Share by Manufacturers in 2019 |
| Figure 16. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine Revenue in 2019 |
| Figure 17. mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 |
| Figure 18. Global mRNA Vaccine Sales Market Share by Region (2015-2020) |
| Figure 19. Global mRNA Vaccine Sales Market Share by Region in 2019 |
| Figure 20. Global mRNA Vaccine Revenue Market Share by Region (2015-2020) |
| Figure 21. Global mRNA Vaccine Revenue Market Share by Region in 2019 |
| Figure 22. North America mRNA Vaccine Sales Market Share by Country in 2019 |
| Figure 23. North America mRNA Vaccine Revenue Market Share by Country in 2019 |
| Figure 24. U.S. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 25. U.S. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 26. Canada mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 27. Canada mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 28. Europe mRNA Vaccine Sales Market Share by Country in 2019 |
| Figure 29. Europe mRNA Vaccine Revenue Market Share by Country in 2019 |
| Figure 30. Germany mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 31. Germany mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 32. France mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 33. France mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 34. U.K. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 35. U.K. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 36. Italy mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 37. Italy mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 38. Russia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 39. Russia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 40. Asia PacifiA Vaccine Sales Market Share by Region in 2019 |
| Figure 41. Asia PacifiA Vaccine Revenue Market Share by Region in 2019 |
| Figure 42. China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 43. China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 44. Japan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 45. Japan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 46. South Korea mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 47. South Korea mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 48. India mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 49. India mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 50. Australia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 51. Australia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 52. Taiwan, China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 53. Taiwan, China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 54. Indonesia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 55. Indonesia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 56. Thailand mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 57. Thailand mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 58. Malaysia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 59. Malaysia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 60. Philippines mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 61. Philippines mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 62. Vietnam mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 63. Vietnam mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 64. Latin America mRNA Vaccine Sales Market Share by Country in 2019 |
| Figure 65. Latin America mRNA Vaccine Revenue Market Share by Country in 2019 |
| Figure 66. Mexico mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 67. Mexico mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 68. Brazil mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 69. Brazil mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 70. Argentina mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 71. Argentina mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 72. Middle East and Africa mRNA Vaccine Sales Market Share by Country in 2019 |
| Figure 73. Middle East and Africa mRNA Vaccine Revenue Market Share by Country in 2019 |
| Figure 74. Turkey mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 75. Turkey mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 76. Saudi Arabia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| グローバルのmRNAワクチン業界分析と動向分析レポート2020-2026 |
| Figure 77. Saudi Arabia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 78. U.A.E mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses) |
| Figure 79. U.A.E mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 80. Sales Market Share of mRNA Vaccine by Type (2015-2020) |
| Figure 81. Sales Market Share of mRNA Vaccine by Type in 2019 |
| Figure 82. Revenue Share of mRNA Vaccine by Type (2015-2020) |
| Figure 83. Revenue Market Share of mRNA Vaccine by Type in 2019 |
| Figure 84. Global mRNA Vaccine Sales Growth by Type (2015-2020) (K Doses) |
| Figure 85. Global mRNA Vaccine Sales Market Share by Application (2015-2020) |
| Figure 86. Global mRNA Vaccine Sales Market Share by Application in 2019 |
| Figure 87. Global Revenue Share of mRNA Vaccine by Application (2015-2020) |
| Figure 88. Global Revenue Share of mRNA Vaccine by Application in 2020 |
| Figure 89. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 90. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 91. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 92. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 93. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 94. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 95. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 96. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 97. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 98. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 99. Price Trend of Key Raw Materials |
| Figure 100. Manufacturing Cost Structure of mRNA Vaccine |
| Figure 101. Manufacturing Process Analysis of mRNA Vaccine |
| Figure 102. mRNA Vaccine Industrial Chain Analysis |
| Figure 103. Channels of Distribution |
| Figure 104. Distributors Profiles |
| Figure 105. Porter's Five Forces Analysis |
| Figure 106. North America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) |
| Figure 107. North America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 108. Europe mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) |
| Figure 109. Europe mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 110. Latin America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) |
| Figure 111. Latin America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 112. Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) |
| Figure 113. Middle East and Africa mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 114. Asia PacifiA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) |
| Figure 115. Asia PacifiA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 116. Bottom-up and Top-down Approaches for This Report |
| Figure 117. Data Triangulation |
| Figure 118. Key Executives Interviewed |
…
如需購買《Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026》，編號：2733788
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號